AQR Capital Management’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$38.9K Buy
2024
Q4
Sell
2024
Q3
$44K Buy
2023
Q4
Sell
2023
Q3
$91.1K Sell
2023
Q2
$126K Sell
2023
Q1
$459K Sell
2022
Q4
$726K Buy
2022
Q3
$174K Sell
2022
Q2
$769K Sell
2022
Q1
$2.03M Buy